PwC MoneyTree is the go-to source for Venture Capital firms and high-growth startups.
The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data (beginning in 1995), updates on the Venture Capital and high-growth startups ecosystem and relevant insights from PwC’s emerging company services and venture capital tax, audit and advisory professionals. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.
Amid falling deal activity, US companies still raised a record-number of mega-rounds in 2018, with 184 $100M+ funding rounds. There was also a record number of new unicorns this year as 53 US VC-backed companies saw their valuation rise to over $1B.
PwC and CB Insights' Healthcare MoneyTree report brings you a quarterly publication based on US venture capital funding for healthcare-related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers and global healthcare trends.
"2018 was a phenomenal year for US venture capital, with $99.5B invested --- a record-breaking 55 unicorn births, 184 mega-rounds, and funding levels at their highest since 2000 ($119.6B). There certainly continues to be a healthy availability of funds and appetite for investment, while the trend of fewer, bigger deals persists."
Partner, US Pharmaceuticals and Life Sciences , PwC US
Tel: +1 (408) 817 5029